<?xml version="1.0" encoding="UTF-8"?><REUTERS CGISPLIT="TRAINING-SET" LEWISSPLIT="TRAIN" NEWID="1044" OLDID="16365" TOPICS="YES">
<DATE> 3-MAR-1987 10:16:12.11</DATE>
<TOPICS><D>earn</D></TOPICS>
<PLACES><D>sweden</D></PLACES>
<PEOPLE/>
<ORGS/>
<EXCHANGES/>
<COMPANIES/>
<UNKNOWN> 
   F
   f0472 reute
d f BC-PHARMACIA-AB-&lt;PHAB-ST   03-03 0028</UNKNOWN>
<TEXT> 
<TITLE>PHARMACIA AB &lt;PHAB ST&gt;  1986 YEAR</TITLE>
<DATELINE>     STOCKHOLM, March 3 - </DATELINE><BODY>Sales 3.65 billion crowns vs 3.40
billion.
     Profit  after financial items 821.2 mln crowns vs 740.2
mln.
    The 1986 results include a once-off writedown of 520 mln
crowns for intangible assets, mainly the know-how paid for in
the takeover of a number of high-tech companies by the group,
Pharmacia said.
    Earnings per share after real tax including the writedown:
1.94 crowns vs 12.05 crowns.
    Earnings per share after real tax (not including the
writedown): 12.38 crowns vs 12.05
    Earnings per American Depository Receipt (ADR) according to
U.S. Accounting principles after real tax including the
writedown): 1.96 crowns vs 9.49 crowns.
    Earnings per ADR according to U.S. Accounting principles
after real tax (without the writedown): 9.8 crowns vs 9.49.
    One ADR represents 0.75 pct of one B Free share in
Pharmacia.
    The board proposed a dividend of 1.55 crowns vs 1.25.
 REUTER
 </BODY></TEXT>
</REUTERS>